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INTRODUCTION 
Nephrotic syndrome is one of the few modes of clinical expression of 
renal damage consequent upon an insult by a biological or a non-biological 
agent resulting in renal injury by differing mechanisms. The diagnosis 
cannot be complete unless the specific etiology, the mechanism and modes 
of injury to the kidney and the morphological pattern of response by the 
kidney to this injury are understood in a given individual. While planning 
therapy in any form of glomerulonephrtis, one should know about the 
histopathological nature of the disease. Percutaneous needle biopsy is the 
best available aid to the clinician in guiding him to know about the nature of 
the disease. 
 Before the advent of renal biopsy the knowledge of renal pathology 
and in general renal disease was gained almost entirely from the autopsy 
material. 
The value of renal biopsy is that the histological pattern 
1. Does not change from one form to another except is very limited 
instances. 
2. Provides a dependable guideline to the possible future progression 
of the renal lesion, thus indicating the prognosis. 
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3. May indicate the mechanism and mode of injury to the kidney, 
thus guiding the therapeutic approach. 
4. May bring out the etiological agent in some cases. 
Unlike other diseases, renal diseases are so complicated that a single 
lesion may manifest in different ways in different individuals, clinical 
presentation may vary from patient to patient and this is the reason for much 
of the misunderstanding in the nature of this group of diseases. This is 
because, the kidney reacts in a similar way to a number of insults.  The terms 
acute, subacute and chronic glomerulonephritis to describe the clinical 
presentation do not provide the proper basis for understanding the nature of 
the renal injury. Renal biopsy and histopathological study are the keys to 
understand the nature of the renal damage.  This is important for both the 
treatment strategy and prognostication.  As said before, since the advent of 
renal biopsy, there has been a gradual elimination of clinical terms and an 
attempt instead to achieve histopathological diagnosis based on 
morphological features present in the glomerulus and various attempts have 
been made to study clinicopathological correlations in the different types of 
glomerulopathies in order to establish their significance.  
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HISTORICAL REVIEW 
 Cotunnius in the year 1770 was the first to record the association 
between edema and the presence of coagulable substances in the urine. In 
1827 Richard Bright correlated albuminuria and the symptoms of glomerular 
diseases. In 1917 Epstein suggested that the edema was due to 
hypoalbuminemia as a result of proteinuria and called as Epstein syndrome. 
 In 1905 Friiedrich muller introduced the term Nephrosis since the 
characteristic inflammatory reactive changes of nephritis were not present in 
the glomeruli of nephrotic patients. In 1908 munk and in 1914 volhard and 
Fahr observed in patients with edema and albuminuria that renal changes 
consisted principally of infiltration of the tubules by birefractile lipoid 
substances. Dunn in 1934 published a paper stating that albuminuria might 
be due to excessive permeability of glomerular capillaries. Ellis in 1942 
called nephrotic syndrome as a type II nephritis. In 1946 Bell, described a 
group of patients with nephrotic syndrome in whom the glomeruli were not 
inflamed but the glomerular basement membrane appeared thickened. He 
seems to have been the first person to use the term membranous 
glomerulonephritis. Focal glomerulonephritis has long been associated with 
subacute bacterial endocarditis dating from the classic description of flea 
bitten kidney by lohlein (1910). 
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 The first renal biopsy was done by Gunta in 1916. In 1929, Dorothy 
Russel brought out a monogram on renal biopsy. In 1950, Perea reported 
percutaneous renal biopsy as a safe procedure. This was furthur confirmed 
by Iverson and Burn in 1951. Its modification in supine position was given 
by Kark and Muehrcke in 1954. 1 Sarin’s publications are among the earliest 
in our country on percutaneous renal biopsy. In 1968, Pasternack suggested 
fine needle aspiration cytology of the kidney in the diagnosis of acute 
rejection. In 1985, Kawamura described open renal biopsy and in 1987 there 
was modification of Kawamura open renal biopsy forceps. 
 The precise relationship between serum complement and 
glomerulonephritis was observed by Kellet in 1935, though the lowered 
levels of complement  in this  disease were first discovered by Gunn as early 
as 1914. The experimental proof that the complement causes renal damage 
was provided by schwab. The association between low complement and 
membranoproliferative glomerulonephritis was first noted by West in 1965 
and the role of C3 Nephritic factor in complement activation was elucidated 
by Spitzer in 1969.  
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NEPHROTIC SYNDROME – REVIEW OF 
LITERATURE 
 
 Nephrotic syndrome is a clinical complex characterised by massive 
proteinuria, hypoalbuminemia, edema, hyperlipidemia, lipiduria and 
hypercoagulability. Proteinuria is the key component of this syndrome. The 
total urinary protein excretion rate in excess of 3.5gm per 1.73m2 body 
surface area per day is considered to be in the nephrotic range. Massive 
proteinuria alone has now come to define the syndrome since this finding 
reflects serious renal disease whether or not the protein loss lead to 
hypoalbuminemia, lipid disturbances or edema. 
 
Causes of Nephrotic syndrome: 
I  Primary Glomerular diseases: 
Minimal change disease  
Focal and segmental glomerulosclerosis 
Membranous glomerulopathy  
Membranoproliferative glomerulonephritis  - Type I, II , III , other variants 
Mesangialproliferative glomerulonephritis  
Focal and segmental proliferative glomerulonephritis  
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II Secondary to other Diseases  
(A) Infections  
Bacterial Post streptococcal glomerulonephritis 
  Infective endocarditis  
Shunt nephritis 
Leprosy 
Syphilis (congenital and secondary) 
Mycoplasma 
Tuberculosis  
Chronic bacterial pyelonephritis 
 Viral  Hepatitis – B, C 
Cytomegalovirus  
Epstein Barr virus  
Herpes Zoster 
Vaccinia 
HIV type I 
 Protozoal  Malaria 
   Toxoplasmosis 
 Helminthic Schistasomiasis 
   Trypanosomiasis 
   Filariasis 
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(B) Neoplasia 
Hodgkin’s disease 
Chronic lymphocytic leukemia  
Multiple myeloma  
Lymphomas  
Carcinomas  
Melanoma  
Wilm’s tumour 
 (C) Medications 
 Organic, inorganic elemental mecury  
 Organic gold    
 Penicillamine    
 Street heroin  
 NSAIDS   
 Probenecid   
 Captopril    
 Lithium    
 Mephenytoin   
 Tolbutamide 
 Chlorpropamide 
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 Rifampicin 
 γ- interferon 
 Warfarin 
 Contrast media 
 Antivenom 
 Antitoxin 
 
(D) Multisystem diseases: 
 Systemic lupus erythematosus  
 Mixed connective tissue disease 
 Dermatomyositis 
 Rheumatoid arthritis 
 Goodpasture disease 
 Henoch –Schonlein purpura 
 Systemic vasculitis  
Mixed Cryoglobulinaemia 
 Takayasu arteritis 
 Sarcoidosis  
 Amyloidosis 
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 (E)   Heredofamilial and metabolic diseases:  
 Diabetes mellitus 
 Hypothyroidism  
 Grave’s disease  
 Amyloidosis  
 Alport syndrome  
 Sickle cell disease 
 α1 -antitrypsin deficiency  
 Nail- Petella syndrome  
 Von Gierke disease  
  (F)  Miscellaneous: 
 Pre –eclampsia 
 Renal artery stenosis  
 Massive obesity  
 Cyanotic congenital heart disease  
 Constrictive pericarditis 
 Severe congestive cardiac failure  
 Vesico ureteric reflux nephropathy  
 Kartagener syndrome 
 
 19
Proteinuria: 
 Proteinuria is the key component of this syndrome and results from 
altered permeability of glomerular filtration barrier for protein–namely the 
glomerular basement membrane and the podocytes and their slit diaphragm 
and perturbation of negative electrostatic charge in glomerular basement 
membrane barrier. When the glomerular capillary membrane permeability 
increases by 10 fold the urinary albumin excretion increases 100 fold. The 
extent of glomerular injury can be assessed by selectivity of proteinuria. A 
highly selective proteinuria consists almost exclusively of albumin and 
indicates minimal glomerular damage. A poorly selective proteinuria 
contains higher molecular weight proteins and indicates a severe renal 
damage. Larger proteins such as IgM, fibrinogen, α1 and α2 macroglobulin 
and larger lipoproteins never traverse the glomerular capillary wall and thus 
are of normal or increased concentration in the plasma. 
Hypoalbuminemia: 
 The hypoalbuminemia is due to excessive urinary losses, increased 
renal catabolism, excessive gastrointestinal losses, increased trans-capillary 
escape of albumin and inadequate hepatic synthesis. The availability of drug 
binding sites may be restricted by hypoalbuminemia which may lead to high 
levels of free drug enhancing the potential for drug toxicity. 
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Edema: 
 Edema of nephrotic syndrome is due to salt and water retention. 
Hypoalbuminemia reduces the intravascular oncotic pressure that leads to 
leakage of extracellular fluid from the blood to the interstitium.  This 
reduces the intravascular volume, thereby initiating a series of homeostatic 
adjustments designed to correct the defect in effective plasma volume.  
These include activation of renin angiotensin aldosterone system, enhanced 
vasopressin secretion, stimulation of sympathetic nervous system and 
suppression of atrial natriuretic peptide release. 2 In some patients, the 
plasma volume is expanded and renin-angiotensin –aldostetone axis is 
suppressed suggesting that primary renal salt and water retention also 
contributes to edema formation. 3 In many instances, edema is a bothersome 
but not debilitating clinical feature, but occasionally it can be severe and 
associated with ascites, pleural effusion and pericardial effusion. In the 
periphery, it is characteristically soft and easily pitting and accumulates in 
areas of low tissue pressures such as the periorbital areas. It is usually worse 
about the face upon arising and increases in dependent areas with activity 
and upright posture. 
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Hyperlipidemia and lipiduria: 
 Hyperlipidemia is a frequent accompaniment of the nephrotic state. It 
is a consequence of both increased hepatic synthesis and decreased 
catabolism of individual lipid fractions. Decreased plasma oncotic pressure 
stimulates the hepatic synthesis of apoprotein-B containing lipoproteins. 5,6,7 
Depletion of endothelial bound lipoprotein lipase and alteration in the 
binding capacity of very low density lipoproteins are thought to contribute to 
the decreased catabolism of lipoproteins. 8 Lowered plasma visocity, 
reduced oncotic pressure, reduced plasma tonicity, urinary loss of 
liporegulatory substances and decreased lipoprotein lipase activity may all 
play a role in the genesis of hyperlipidemia.  Total plasma cholesterol and 
low density lipoproteins are increased in the majority of patients, whereas 
very low density lipoproteins and triglycerides tend to rise in patients with 
severe diseases. 5 Lipiduria is a sign of disordered lipid metabolism and is 
due to excessive filtration of low molecular weight high density lipoprotein. 
Hypercoagulability: 
 This is probably multifactorial in origin and is a consequence of 
hyperfibrinogenemia, increased in vitro platelet hyperaggregability, 
increased fibrinogen-to- fibrin transition, altered level and activity of protein 
C and S, decreased levels of antithrombin III and decreased fibrinolysis. 10,11  
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These abnormalities may result in venous and arterial thrombi. Low 
antithrombin III level in nephrotic patients may not only be due to urinary 
loss but also to intravascular consumption. Steroid administration alters the 
level of certain coagulation factors and may provide another stimulus to 
procoagulant activity. Increased platelet aggregability, increased levels of 
Von Willebrand factor and β-thromboglobulin promote procoagulant 
activity.  The cause of enhanced platelet aggregability is most likely 
multifactorial, with hypoalbuminemia, hyperlipidemia and 
hyperfibrinogenemia all palying a role. 13 
 
 The patients can develop spontaneous peripheral arterial and venous 
thrombosis, renal vein thrombosis and pulmonary embolism. Acute renal 
vein thrombosis is characterised clinically by sudden onset of 
flank/abdominal pain, gross hematuria, left sided varicocele, increased 
proteinuria and acute decline in glomerular filtration rate. Chronic renal vein 
thrombosis is usually asymptomatic.  Renal vein thrombosis is common in 
patients with nephrotic syndrome due to membranous glomerulopathy, 
membranoproliferative glomerulonephritis and amyloidosis. 14 
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Functional Consequence of Urinary loss of plasma 
proteins: 
 In addition to hypoalbuminemia, hormone binding proteins are 
typically lost in the urine resulting in several endocrine and metabolic 
abnormalities. Urinary loss of thyroid binding globulins and thyroxine T4 
results in a low T4 (both free and  bound) and total T3 level is reduced due to 
decreased binding to thyroid binding globulins. Total reverse T3 level is 
normal but free reverse T3 is elevated. 15 These changes are associated with 
hypothyroidism in neptrotic patients. Although most of them remain 
clinically euthyroid, free T4 level and TSH level are the best markers for the 
status of thyroid function. 
 Hypocalcemia and secondary hyperparathyroidism can occur as a 
consequence of Vit D deficiency due to increased urinary excretion of 
cholecalciferol- binding protein and also to low serum concentration of total 
1,25 dihydroxy cholecalciferol. 16 
The patients with nephrotic syndrome have increased susceptibility to 
infection due to loss of immunoglobulin in urine and defects in complement 
cascade.  Peritonitis is caused by either Gram-negative (or) Gram-positive 
organism and remains a serious complication of the nephrotic syndrome. 
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Complications of Nephrotic Syndrome: 
1. Increased susceptibility to infections. 
2. Thrombosis and thromboembolism. 
3. Hyperlipidemia and Premature coronany atherosclerosis and increased 
incidence of myocardial infarction. 
4. Protein malnutrition. 
5. Iron- resistant microcytic  hypochromic anemia. 
6. Hypocalcemia and secondary hyperparathyroidism. 
7. Hypothyoidism. 
8. Unpredictable drug pharmacokinetics and drug toxicity. 
9. Acute renal failure. 
Infections: 
 A number of immunological abnormalities have been documented in 
patients with nephrotic syndrome.  These include depressed immunoglobulin 
levels due to urinary loss, impaired antibody production, defective 
opsonization due to depressed levels of complement factor B and 
abnormalities of cellmediated immunity.  Non-specific depression of 
immune response may occur because of malnutrition and vitamin D 
deficiency or immunosuppressive therapy.  These abnormalities may result 
in increased susceptibility to infection.  The peritoneum and lungs are the 
sites most commonly involved.   
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Primary peritonitis is particularly characteristic of nephrotic children.  
The microorganisms commonly involved in peritonitis are Streptococcus 
pneumoniae, β-hemolytic streptococcus, Hemophilus influenzae and also 
Gram-negative bacteria. 
Cellulitis is also characteristic in severely edematous nephrotics.  This 
arises from skin punctures either spontaneously or as a result of 
venepuncture.  The microorganism responsible include β-haemolytic 
streptococci and a variety of Gram-negative bacteria. 
Thrombosis and Thromboembolism: 
 This is mainly due to hypercoagulability in nephrotic patients. The 
patients can develop spontaneous peripheral arterial and venous thrombosis, 
renal vein thrombosis and pulmonary embolism. Acute renal vein 
thrombosis is characterised clinically by sudden onset of flank/abdominal 
pain, gross hematuria, left sided varicocele, increased proteinuria and acute 
decline in glomerular filtration rate. Chronic renal vein thrombosis is usually 
asymptomatic.  Renal vein thrombosis is common in patients with nephrotic 
syndrome due to membranous glomerulopathy, membranoproliferative 
glomenlonephritis and amyloidosis. 
 20% of adult nephrotic patients develop thromboembolic 
manifestation. Arterial thrombosis is less frequent than venous thrombosis 
and occurs mainly in pulmonary, femoral, mesenteric and coronary arteries. 
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Abnormal calcium homeostasis: 
 Hypocalcemia and secondary hyperparathyroidism in nephrotic 
patients are due to reduced intestinal absorption of calcium and blunted 
calcemic response to parathyroid hormone.  Levels of 25-hydroxy 
cholecalciferol is reduced in nephrotic patients due to loss of this metabolite 
in urine bound to its vitamin D carrier protein. 16 Severe bone 
demineralization and bone resorption occurs only in patients with renal 
insufficiency. 
Anemia: 
 Iron-resistant microcytic hypochromic anemia in nephrotic patients is 
due to urinary loss of transferrin and decreased level of erythropoietin. 
Protein malnutrition: 
 This is due to proteinuria, tubular catabolism and inadequate 
compensation by liver. 
Treatment of Nephrotic syndrome: 
 This involves 1. Specific treatment of underlying morphologic entity 
and if possible causative disease. 2. General measures to control proteinuria 
if remission is not achieved through immuno suppressive therapy and other 
specific measures 3. General measures to control nephrotic complications. 
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Proteinuria: 
Non-specific measures: 
1. Angiotensin converting enzyme inhibitors. 
2. Angiotensin receptor blockers. 
3. Nonsteroidal antiinflammatory drugs. 
Angiotensin converting enzyme inhibitors and Angiotensin receptor 
blockers reduce the proteinuria and slow the rate of progression of renal 
failure by lowering intraglomerular pressure and preventing the development 
of hemodynamically mediated focal segmental glomerulosclerosis. These 
drugs are renoprotective in diabetic nephropathy and many other proteinuric 
glomerulopathies including secondary focal segmental glomerulosclerosis.  
The antiproteinuric effect of angiotensin converting enzyme inhibitors is 
dose dependent and independent of changes in systemic blood pressure and 
also appears to depend on sodium restriction. 
Nonsteroidal antiinflammatory drugs also reduce proteinuria by 
altering glomerular hemodynamics and glomerular basement membrane 
permeability, due to inhibition of renal prostaglandin synthesis.  The 
beneficial effect of these drugs occurs more rapidly than that of Angiotensin 
converting enzyme inhibitors, but they are associated with number of 
adverse effects like hyperkalemia, renal failure and salt and water retention. 
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EDEMA: 
 The edema should be managed by moderate salt restriction usually 1-2 
gm /day and judicious use of diuretics. Complete resolution of edema is not 
only unattainable but also undesirable because of risk of volume depetion. In 
case of mild edema, dietary salt restriction alone is enough.  The compliance  
with sodium restriction can be ascertained by measuring 24 hours urinary 
sodium excretion.  Patients weight should be taken daily.  Mild diuretics 
including thiazide may be sufficient in patients with mild edema.  
Potassium-sparing diuretics like spironolactone are useful in those patients 
in whom hypokalemia becomes a clinical problem.  Loop diuretics like 
furosemide are typically used for moderate to severe nephrotic edema. 
Metalazone may be effective when used alone or in combination with loop 
diuretics, in patients with refractory nephrotic edema. 
 
 In patients treated with diuretics, profound volume depletion may 
occur that leads to peripheral vasoconstriction, tachycardia, orthostaic 
hypotension, oliguria, and renal insufficiency. This needs rehydration and 
cessation of diuretics. 
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 Albumin infusions that increase the plasma volume, are most useful in 
patients with profound volume depletion. 4 But they are usually excreted 
within 48hrs. and may also result in pulmonary edema. In extreme cases 
with marked edema, especially with pulmonary edema in the setting of 
reduced glomerular filtration rate, intermittent continuous extracorporeal 
dialysis is useful. 
Hyperlipidemia: 
 Lipid lowering drugs prevent the accelerated atherosclerosis and 
possibly slow the progression of renal insufficiency and decrease the 
incidence of myocardial infarctions. 
 The drugs most commonly used are HMG COA reductase inhibitors 
and bile acid sequestrants like cholestyramine and colestipol. HMG COA 
reductase inhibitors reduce the total and LDL cholesterol levels by 10-45% 
coupled with reduction in triglyceride levels. 9 Bile acid sequestrants lower 
the total cholesterol levels by upto 30%. Fibric acid derivatives like 
gemfibrozil, clofibrate lower cholesterol by 10-30% and also lower plasma 
triglycerides and may raise HDL level but they are associated with increased 
risk of myopathy. At present, HMG COA inhibitors are the treatment of 
choice.  
 Intake of vegetable diet rich in polyunsaturated fatty acids reduces the 
lipid level by 25-30%. 
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Hypocalemia: 
 Oral vitamin D therapy should be given for patients with evidence of 
osteomalacia or secondary hyperparathyroidism, patients with persistently 
low serum ionized calcium levels, patients in whom progressive renal 
insufficiency is anticipated, and patients who have unremitting or frequently 
relapsing nephrotic syndrome. 17 
Serum calcium levels should be monitored closely in patients on 
vitamin D replacement therapy.  Measurement of bone mineral density 
should be considered in patients with persistent nephrotic syndrome, 
particulary if they have received high doses of corticosteroids or have 
additional risk factors for osteoporosis. 
Thromboembolism: 
 Patients with a history of thromboembolism prior to the onset of 
nephrotic syndrome should receive prophylactic anticoagulation if they are 
immobilized or have other major risk factors for clotting.  In patients who 
experience an episode of thrombus or embolus, anticoagulants should be 
continued for as long as the nephrotic state persists.  Intravenous heparin 
followed by warfarin is the standard treatment for acute renal vein 
thrombosis. 11,14 International normalized ratio must be carefully monitored 
during the anticoagulation therapy.  Prolonged immobilization and volume 
depletion should be avoided.  
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Infection: 
 The patient should be treated with intravenous broad spectrum 
antibiotics covering both Gram-positive and Gram-negative organism.  
Prophylatic use of antibiotics, pneumococcal vaccine, or intravenous 
administration of hyperimmune globulin should be considered in high-risk 
cases.  Vaccination should be given whenever possible during periods of 
remission, as nephrotic syndrome may impair the antibody response to 
vaccination.  Pneumococcal vaccination is still recommended for children 
over 2 years of age and for adults with severely depressed immunoglobulins, 
particularly if nephrotic syndrome is likely to be persistent or if renal failure 
supervenes. 
Minimal Change disease: 
Minimal change disease is the most common cause of the nephrotic 
syndrome in children and is not uncommon in adults. The clinical 
presentation is similar in old and young but older individuals are much more 
likely to have nonselective proteinuria, microscopic hematuria, hypertension 
and renal insufficiency. 22,26 Classically the disease appears soon after a viral 
respiratory tract infection.  
 
 
 
 32
Pathology: 
There are no changes on light microscopy (or) only slight membrane 
thickening and mesangial proliferation. There are no immune deposits but 
findings of mesangial hypercellularity and sparse deposits   of C3 and IgM 
portend a worse prognosis. 18 Electron microscopy reveals characteristic 
diffuse effacement of foot process of visceral epithelial cells. (foot process 
fusion).  
Treatment: 
This disease is highly responsive to steroids and carries an excellent 
prognosis. Spontaneous remission occurs in 30-40% of childhood cases but 
is less common in adults. Adult patients have to be treated with oral 
prednisolone 1-1.5mg/kg body weight per day for 4 weeks followed by 
1mg/kg per day on alternative days for 4 weeks.  The steroid dependent and 
frequently relapsing patients should be treated with cyclophosphamide        
2-3mg/kg per day or chlorambucil 0.1-0.2mg/kg per day after steroid 
induced remission and continued for 8-12 weeks.  Lorca and ponticelli 
reported that 80% of patients with minimal change disease responded 
initially to steroids or cytotoxic agents, almost a third experienced relapse 
and half of them developed renal failure or died, and they recommended 
treating the patient initially with corticosteroids followed by a cytotoxic 
agent for 12 weeks if steroids are not tolerated or are ineffective. 
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Membranous Nephropathy: 
Membranous nephropathy is the most common cause of nephrotic 
syndrome in the elderly. At least 85% of patients with membranous 
nephropathy present with nephrotic proteinuria. The most common causes of 
secondary membranous nephropathy in elderly are drugs like nonsteroidal 
anti-inflammatory drugs and cancer.  
Brown reported that 11% of patients with membranous nephropathy 
had an underlying malignancy. 21  Males are affected twice as frequently as 
females. 
Clinical Features: 
70-80% of patients presenting with hypoalbuminemia, 
hyperlipidemia, peripheral edema and lipiduria. Hypertension occurs in 13 to 
55% of cases and microscopic hematuria occurs in 70 –80% of cases. 4-52% 
of patients have renal vein thrombosis. Complete spontaneous remission 
occurs 20-40% of cases.  Older patients are more susceptible to the extra 
renal complications of nephrtoic syndrome and its treatment. 22 
Pathology  
Electron Microscopy: 
 Presence of subepithelial immune complex deposits or their structural 
consequences. 
Four ultrastructural stages of membranous glomerulopathy have been 
described by Ehrenreich and Churg. 19 
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Stage I – This is characterized by the presence of scattered or more 
regularly distributed  small immune complex –type electron dense deposits 
in subepithelial zone between the basement membrane and epithelial cells.  
Stage II – This is characterized by projections of basement membrane 
materials around the subepithelial  deposits. 
Stage III – New basement membrane material surrounds the deposits and 
thus in cross section, there is basement membrane material between the 
deposits and the epithelial cytoplasm. 
Stage IV – This is characterized by loss of the electron density of the 
deposits, often resulting in irregular electron lucent zones within an 
irregularly thickened basement membrane. 
Stage V – This is characterized by a repaired outer basement membrane 
zone with only residual basement membrane disturbances in the inner aspect 
of the basement membrane. Mesangial dense deposits are rare in idiopathic 
membranous glomerulopathy but frequent in secondary membranous 
glomerulopathy. 
Light Microscopy: 
 Diffuse global  granular capillary wall thickening in the absence of  
significant glomerular hypercellularity. Stage I lesions may not be 
discernible by light microscopy but stage II, III, IV lesions readily 
discernible. 
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Immuno fluorescence microscopy: 
 Diffuse global granular capillary wall staining for Ig and complement, 
most frequently Ig G and C3. 
Treatment: 
 Spontaneous and complete remission occurs in 40% of the patients.  
Repeated relapses and remission without worsening of renal function occurs 
in 30-40%. 10-20% of the patients suffer a slow progressive decline in 
glomerular filtration rate that typically culminate in end stage renal disease 
after 10-15 years.  In patients with proteinuria less than 3.5 gm/day, the risk 
of progression is low.  The patients should be closely monitored with a low-
salt diet, strict blood pressure control and angiotensin converting enzyme 
inhibitor for reduction of proteinuria.  The patients with proteinuria of 3.5-8 
gm/day but normal renal function are at medium risk and they should follow 
the above suggestion and can be treated by immunosuppressive regimens 
with corticosteroids and chlorambucil or cyclophosphamide for 6 months.  
The highest risk patients-those with more than 8gm/day of proteinuria and 
renal dysfunction must be treated with corticosteroids and cytotoxic agents.  
Renal transplantation is a successful treatment option for patients with end 
stage renal disease. 
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Membranoproliferative Glomerulonephritis: 
 Membranoproliferative glomerulonephritis are usually seen in 
children between the age of 8-16 years and nearly in an equal proportion of 
males and females. Membranoproliferative glomerulonephritis appears to be 
decreasing in frequently. 
Clinical Features: 
 
  Half of the patients present with all the components of the nephrotic 
syndrome and 25% of patients present with a combination of asymptomatic 
hematuria and asymptomatic proteinuria. 25-30% of patients have 
hypertension and renal dysfunction occurs in at least half of the cases. 
 
Pathology: 
 
Electron Microscopy: 
 
Type I – Mesangial interposition into an expanded subendothelial zone that 
contains electron –dense immune complex deposits is the ultrastructural 
hallmark of this type. 23 New basement membrane material is formed around 
the subendothelial deposits and around the projection of mesangial 
cytoplasm. 
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Type II – Dense –deposit disease. Development of discontinuous electron 
dense bands within glomerular basement membrane is the pathognomonic of 
this type.  This is accompanied by spherical to irregular mesangial dense 
deposits and occasionally subendothelial and subepithelial deposits.  
Light Microscopy: 
Type I – Most common histologic feature of this type are diffuse global 
capillary wall thickening and endocapillary hypercellularity. 23 Infiltrating 
mononuclear leukocytes and neutrophils also contribute to the glomerular 
hypercellularity.  The consolidation of glomerular segments that results from 
these changes often causes an accentuation of the segmentation. 
(hypersegmentation or lobulation).  The distinctive feature of this type is 
doubling or more complex replication of glomerular basement membrane.  
Type II – The light microscopic appearance does not always have 
membranoproliferative appearance and can mimic other types of 
glomerulonephritis. Spontaneous remission is uncommon and steroids may 
delay the progression of disease. The course of disease is progressive. 
Prognosis is worse for Type II disease than for Type I, because of frequent 
association with crescentic glomerulonephritis and chronic tubulointerstitial 
nephritis. Poor prognostic factors in idiopathic membranoproliferative 
glomerulonephritis type I include hypertension, impaired glomerular 
filtration rate, nephrotic rather than non-nephrotic disease, cellular crescents 
on biopsy. 
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Mesangioproliferative – glomerulonephritis: 
 In 5-10 % patients with idiopathic nephrotic syndrome, renal biopsy 
reveals a diffuse increase in glomerular cellularity  predominantly due to 
proliferation of mesangial and endothelial cells and infiltration by 
monocytes. Immuno fluorescence microscopy shows deposits of Ig A, IgG, 
IgM and/or complement (or) absence of immuno reactants. This 
morphological entity is a heterogenous group of disease that include a 
typical forms of minimal change disease and focal segmental 
glomerulosclerosis and resolving forms of immune complex and pauci-
immune glomerulopathy. In keeping with the heterogeneity of this diagnosis, 
the prognosis is variable. Persistent nephrotic range proteinuria and renal 
insufficiency signals a poor prognosis with many patients progressing to end 
stage renal disease over 10-20 years despite immuno suppressive therapy. 
Focal Segmental glomerulosclerosis: 
 This pattern has been reported in 7% of renal biopsies of elderly 
nephrotic patients. Juxtamedullary glomeruli are frequently affected with 
positive immunofluorescence for IgM and C3 complement. focal segmental 
glomerulosclerosis is seen often as an end result of other glomerulopathies 
and secondary to advanced systemic diseases like hypertension and diabetes 
mellitus. 24 Clinically this is characterised by varying degree of proteinuria 
from non-nephrotic to nephrotic which is hallmark of the focal segmental 
glomerulosclerosis.  
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Haematuria occurs in 50% of patients and 30% of patients present 
with some degree of renal insufficientcy and 30% of cases are hypertensive 
which is more in adults. The patients with perihilar focal segmental 
glomerulosclerosis accompanied by glomerular hypertrophy, have more 
commonly non-nephrotic range proteinuria than the patients who do not 
have glomerular hypertrophy.  The patients with collapsing variant often 
have more selective proteinuria and renal insufficiency but less hypertension 
than the typical variant.  The patients with glomerular tip lesion variant often 
present with rapid onset of edema similar to minimal change 
glomerulopathy.  High dose oral prednisolone 1-1.5mg/kg/day for 2-
3months followed by a slow steroid taper can induce remission in over half 
of the patients. 
Multiple Myeloma: 
 Almost 50% of patients have overt renal insufficiency at sometime 
during the course of the disease and renal disease may be the first indicator 
of multiple myeloma. The commonest clinical manifestation is detection of 
light chain/ Bence-Jones proterinuria, observed in 65-100% of patients. 
Intratubular obstruction by myeloma protein may result in acute renal failure 
and is not always reversible. Hypertension and hematuria are rare. Renal 
histology shows dilated tubules containing fractured glassy eosinophilic 
casts surrounded by multinucleated giant cells and widespread tubular 
atrophy, interstitial fibrosis and inflammation.  
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On immunofluorescence, the cast shows light chains besides 
immunoglobulins, Tamm-Horsfall protein and complement. Secondary 
amyloidosis occurs in 6-15% of patients. The patients have to be treated with 
adequate hydration, vigorous control of hypercalcemia and hyperuricemia 
and cautious use of potentially nephrotoxic agents. Patients with severe renal 
failure are treated with peritoneal dialysis or plasmaparesis. Survival rate on 
maintanance dialysis is about 50% at 1 year. Renal transplantation should be 
done, only after chemotherapy induced prolonged remission and control of 
tumour growth. 
Renal Amyloidosis: 
 Amyloidosis is characterised by deposition of amyloid fibrils in 
glomenular capillary loops. In primary amyloidosis, these fibrils are light 
chains that have a composition similar to those of Bence Jones proteins. 
Patients with plasma cell dyscrasias often have an amyloidosis similar to that 
seen with primary amyloidosis. Secondary amyloidosis is associated with 
chronic inflammatory diseases such as infections and inflammatory bowel 
diseases. Glomeruli are involved in 75-90% patients usually in association 
with involvement of other organs. The clinical correlate of glomerular 
amyloid deposition is nephrotic –range proteinuria and >50% of patients 
having oliguria and 20-25% presenting with hypertension.  
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Renal failure in amyloidosis is due to amyloid deposition in renal 
vasculature, Fanconi’s syndrome, nephrogenic diabetes insipidus (or) renal 
tubular acidosis due to involvement of tubular interstitium. Rectal biopsy 
and abdominal  fat pad biopsy reveal amyloid deposits in about 70% of 
patients and may obviate the  need for renal biopsy. 
 Earliest pathological changes are mesangial expansion by amorphous 
hyaline material and thickening of the glomerular basement membrance and 
later developed large number of nodular eosinophilic masses. With Gongo 
Red stain, deposits show apple green birefriengence under polarised   light 
and electron microscopy reveals characteristic non-branching extra cellular 
amyloid fibrils. Tubulointerstitial and vascular deposits of amyloid are also 
seen. The patients with primary amyloidosis progress to end stage renal 
disease in average of 2-3 years.  Melphalon and prednisone can reduce 
proteinuria and improved renal function in some patients. Colchicine delays 
the onset of nephropathy. Remission may be achieved in secondary 
amyloidosis by eradication of the underlying cause. Renal transplantation is 
a viable option in patients with secondary amyloidosis whose primary 
diseases has been eradicated. Most of the death is due to infections and 
cardiovascular complications. Recurrence in the allograft is common but 
rarely leads to graft loss. 
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AIMS OF THE STUDY 
 
1. To study the clinical profile, biochemical alteration in renal function 
and histopathological appearance in renal biopsy in 25 cases of 
nephrotic syndrome in elderly patients. 
 
 
2. To diagnose the etiology. 
 
 
3. To correlate the histopathological appearance with the clinical 
features and biochemical findings. 
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MATERIALS AND METHODS 
 To predict the prognosis and the line of management in a patient with 
nephrotic syndrome, we depend upon the histopathological examination of 
renal tissue. So the renal biopsy forms the corner stone in the line of 
management of any patient with nephrotic syndrome. The percutaneous 
renal biopsy if performed by a well trained person, has a low complication 
rate. Some patients may not be willing to subject themselves to this 
procedure. In this study, the renal biopsy was carried out without ultrasound 
guidance. The ultrasound guided biopsy gives better results. 
Selection Criteria: 
1. The patients with clinical features suggestive of nephrotic syndrome 
were included. 
2. The patients above the age of 50 years and of both sexes were 
included. 
3. The patients having nephrotic range proteinuria only were included. 
Period of the study: 
 From December 2003 to July 2005. 
 
No. of cases studied: 25 
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 All patients who were admitted in the medical wards and in the 
nephrology ward of Thanjavur Medical College Hospital from December 
2003   to July 2005   with clinical features suggestive of nephrotic syndrome 
were taken up for this study. The patients above the age of 50 years and both 
sexes were included. The patients were included in this study only when the 
proteinuria was in the nephrotic range. 
The methods of examination included are  
1. Clinical Examination.  
2. Urine Examination. 
3. Biochemical Examination. 
4. Histopathological Examination. 
Urine Examination: 
1. Albumin by heat coagulation method.  
2. Sugar by Benedict’s method. 
3. Deposits for red blood cells, various casts & cells.  
4. 24 hours urine protein estimation.  
5. Urine culture in selected cases.  
6. Urine Bence-Jones protein in selected cases.  
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Bio chemical Examination: 
1. Blood sugar.  
2. Blood urea. 
3. Serum creatinine. 
4. Serum electrolytes. 
5. Serum Cholesterol.  
6. Serum total protein. 
7. Serum electrophoresis in selected cases. 
Plain X-ray Abdomen KUB was taken in all patients to locate the site 
of kidney to be biopsied. An abdominal ultrasound was done in all patients 
to assess the kidney size and to rule out other structural abnormalities. 
Before renal biopsy, the coagulation profile like bleeding time, clotting time, 
and blood grouping was done for all patients and haematological disorders 
were ruled out and two units of blood were reserved. Informed consent was 
obtained from the patients before renal biopsy. 
Procedure: 
Three types of needles can be used for renal biopsy  
1. Inversum and Brun. 
2. Franklin’s Modification of VIM Silverman needle. 
3. TRU- CUT needle. 
In this study ‘TRU –CUT –NEEDLE’ was used. 
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Techique of Renal Biopsy: 
The patient is placed prone, straight and flat on his belly with a sand 
bag between the costal margin and the iliac crest. After the patient is 
positioned the kidney can be marked on the back of the patient. The skin is 
prepared by cleaning with cetavlon and betadine solution. A small area of 
skin around the skin mark is anaesthetized by 2% xylocaine infiltration. 
 A small incision about 2-3mm is made at the point of biopsy with 
No.11 B.P scalpel blade. The depth of the kidney from the skin surface is 
assessed by inserting a disposable lumbar puncture needle. As the patient 
holds the breath, the needle is advanced. It will encounter resistance of the 
subcutaneous tissue, paraspinal muscles and renal capsule in succession. As 
soon as the capsule is pierced a ‘give’ is felt. The patient is asked to breathe 
freely. The needle will show a forward and backward movement.  The 
lumbar puncture needle is withdrawn and the depth was noted.  This is 
marked on the biopsy needle. 
 The patient is asked to hold his breath once again. The biopsy needle 
is advanced to the desired depth. The needle is left in position and the patient 
is asked to breathe. The needle will execute movement. The patient is told to 
hold his breath again and the biopsy is done.  Two bits are taken –one 
superficial and one deep to ensure that the cortico-medulary region is 
included in the biopsy.  
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The diseases such as focal glomerulosclerosis in which the lesion 
commences in the juxta medullary region will not be missed. The whole 
assembly is withdrawn. The renal tissue is preserved in saline and the 
material is sent for histopathological examination. 
 Tincture benzoin seal with a thick pad of gauze is secured at the 
biopsied site. The patient lies still in bed for a few hours. The patient is 
observed for haematuria for the next twenty four hours.  
 
Complications  
1. Local pain. 
2. Microscopic haematuria. 
3. Frank haematuria. 
4. Tear in kidney. 
5. Perirenal hematoma. 
6. Infection. 
7. Arterio – venous fistula. 
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OBSERVATION AND RESULTS 
 
 All observations made are recorded in various tables. Totally 25 cases 
of nephrotic syndrome are studied with renal biopsy. 
 
Table I 
 
AGE INCIDENCE 
 
Age in Years 
Pathological 
lesion 
Total 
No. 
of 
Cases 
M
a
le
 
Fe
m
a
le
 
50
-
55
 
56
-
60
 
61
-
65
 
66
-
70
 
71
-
75
 
76
-
80
 
Membranous 
Nephropathy 11 8 3 5 2 3 1 - - 
Membrano 
Proliferative 4 3 1 3 1 - - - - 
Mesangio 
Proliferative 4 4 0 2 1 - - 1 - 
Focal segmental 
glamerulo 
sclerosis 
1 0 1 1 - - - - - 
Chronic 
glomerulonephritis 1 0 1 1 - - - - - 
Acute interstitial 
nephritis 1 1 0 - 1 - - - - 
Multiple myeloma 1 1 0 1 - - - - - 
Amyloidosis 2 1 1 - - 1 1 - - 
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The minimum age noted is 51 years, the maximum 71 years of age. 
Major incidence was noted in the 50-55yrs of age group (52%). The 
minimum incidence was noted in the 71-75 years of age group (4%). 
 
Table II 
 
SEX INCIDENCE 
 
Sex No. of cases Percentage 
Male 18 72% 
Female 7 28% 
 
Sex incidence noted in this study- male to female ratio is 7:3 
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SEX INCIDENCE 
72%
28%
MALE FEMALE
 
0 2 4 6 8 10
Membranous
Nephropathy
Membrano
Proliferative
Mesangio
Proliferative
Focal segmental
glamerulo sclerosis
Chronic
glomerulonephritis
Acute interstitial
nephritis
Multiple myeloma
Amyloidosis
Male Female
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Table III 
 
PRESENTING SIGNS AND SYMPTOMS 
 
Presenting 
signs & 
Symptoms 
M
em
br
a
n
o
u
s 
M
em
br
a
n
o
 
pr
o
lif
er
a
tiv
e 
M
es
a
n
gi
o
 
pr
o
lif
er
a
tiv
e 
Focal 
segmental 
glomerulo 
sclerosis 
Chronic 
glomerulo 
nephritis 
Acute 
Interstitial 
nephritis 
(Native 
drug) M
u
lti
pl
e 
m
ye
lo
m
a
 
A
m
yl
o
id
o
sis
 
 
Mode of 
Onset 
a) Acute 
b) Gradual 
 
 
- 
11 
 
 
- 
4 
 
 
- 
4 
 
 
- 
1 
 
 
- 
1 
 
 
1 
- 
 
 
- 
1 
 
 
- 
2 
Anasarca 11 4 4 1 1 1 1 2 
Oliguria 5 2 3 - 1 1 - 2 
Ascites 4 3 1 - - - - - 
Hypertension 3 1 4 - - - - - 
 
In all the cases, it was of gradual onset except in native drug ingestion 
where it was sudden onset.  The duration of   onset varying between 1 month 
to 5 months. Anasarca was the major complaint of all the cases(100%). 
Scanty mictuirition was present in 56% of cases. Ascites was present in 32% 
of cases. Hypertension was noted in 32% of cases. 
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PRESENTING SIGNS AND SYMTOMS
0 2 4 6 8 10 12
Membranous
Membrano proliferative
Mesangio proliferative
Focal segmental glomerulo
sclerosis
Chronic glomerulo
nephritis
Acute Interstitial nephritis
(Native drug)
Multiple myeloma
Amyloidosis 
Anasarca Oliguria Ascites Hypertension
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Table IV 
 
URINARY FINDINGS 
 
Urine 
investigation 
M
em
br
a
n
o
u
s 
M
em
br
a
n
o
 
pr
o
lif
er
a
tiv
e 
M
es
a
n
gi
o
 
pr
o
lif
er
a
tiv
e 
Focal 
segmental 
glomerulo 
sclerosis 
Chronic 
glomerulo 
nephritis A
cu
te
 
In
te
rs
tit
ia
l 
n
ep
hr
iti
s 
M
u
lti
pl
e 
m
ye
lo
m
a
 
A
m
yl
o
id
o
sis
 
24 hrs urine 
protein 
< 3.0gm 
- - - - - - - - 
3.0 – 4.0 gm 8 3 2 1 - - - 1 
4.1 – 5.0 gm 3 - 2 - 1 - - - 
> 5.0 gm - 1 - - - 1 1 1 
Microscopic 
hematuria 
< 5 cells / 
hpf 
4 1 - - 1 - - - 
5 – 10 cells / 
hpf 2 1 - - - - - - 
> 10 cells / 
hpf - - - - - - - - 
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Nephrotic syndrome was diagnosed on the basis of 24 hours urinary 
protein excretion per 1.73m2 body surface area per day. In three cases with 
proteinuria between 3.0 to 3.5gms, the proteinuria was in the nephrotic range 
when correlated with body surface area. 
 
The average proteinuria noted in the various groups is given in table VI 
 
Membranous Lesion 3.88 gm/24 hours 
Membrano Proliferative 4.05 gm/24 hours 
Mesangio proliferative 4.04gm/24 hours 
Focal segmental glomerulo Sclerosis 3.86 gm /24 hours 
Chronic glomerulonephritis 4.20gm/24 hours 
Chronic interstitial nephritis (native 
drug intake) 6.73 gm/24 hours 
Multiple myeloma 6.8 gm / 24 hours 
Amyloidosis 3.78 gm / 24 hours 
 
 Microscopic hematuria was noted in 9 cases (36%) 
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Table V 
BIOCHEMICAL FEATURES 
Biochemical 
investigation Range No. of cases Percentage 
< 40 mg% 17 68 % 
Blood urea 
> 40 mg% 8 32 % 
< 1.0 mg% 7 28 % 
1.0 - 2.0 mg% 10 40 % Serum creatinine 
> 2.0 mg% 8 32 % 
< 200 mg% - - 
201 – 300 mg% 15 60 % 
301 – 400 mg% 8 32 % 
401 – 500 mg% 2 8 % 
Serum cholesterol 
> 500 mg % - - 
3.0 – 4.0 gm% - - 
4.1 – 5.0 gm% 11 44 % Serum protein 
5.1 – 6.0 gm% 14 56 % 
 
Blood urea in this study ranged from 24 mg% to 108 mg%. Serum 
creatinine ranged from 0.8 to 3.8 mg%. Serum cholesterol ranged from 234 
mg% to 420mg %  and serum proteins ranged from 4.4gm to 5.8gm%. High 
blood urea and serum creatinine was noted in membranous, 
membranoproliferative, mesangioproliferative, amyloidosis and multiple 
myeloma. Serum electrocytes were normal in all the cases. 
 The average serum proteins, serum cholesterol, blood urea and serum 
creatinine noted in various groups of lesions is given is Table VI.  
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Table VI 
MAJOR CLINICAL AND BIOCHEMICAL FINDINGS FOR 
EACH INDIVIDUAL HISTOLOGICAL GROUPS AMONG 25 
CASES OF NEPHROTIC SYNDROME 
Particulars 
M
em
br
a
n
o
u
s 
M
em
br
a
n
o
 
pr
o
lif
er
a
tiv
e 
M
es
a
n
gi
o
 
pr
o
lif
er
a
tiv
e 
Focal 
segmental 
glomerulo 
sclerosis C
hr
o
n
ic
 
gl
o
m
er
u
lo
 
n
ep
hr
iti
s 
A
cu
te
 
In
te
rs
tit
ia
l 
n
ep
hr
iti
s 
M
u
lti
pl
e 
m
ye
lo
m
a
 
A
m
yl
o
id
o
sis
 
Total No. of 
cases 
11 4 4 1 1 1 1 2 
Age in years 
59 
(52 to 
66) 
54 
(51 to 
58) 
58 
(52 to 
71) 
55 54 56 55 68 
Anasarca 100 % 100 % 100 % 100 % 100 % 100 % 
100 
% 
100 
% 
Hypertension 12 % 4 % 16 % - - - - - 
24 hrs urine 
protein in 
gms 
3.88 
(3.31 
to 
4.66) 
4.05 
(3.20 
to 
5.59) 
4.04 
(3.80 
to 
4.25) 
3.86 4.2 6.73 6.8 3.78 
Serum total 
protein in    
gm % 
5.0  
(4.4 
to 
5.7) 
5.4 
(4.8 to 
5.7) 
5.4 
(4.8 to 
5.8) 
5.6 4.8 5.7 5.5 5.6 
Serum 
Cholesterol in 
mg % 
289 
(234 
to 
372) 
274 
(240 to 
286) 
370 
(310 to 
420) 
256 380 294 248 300 
Blood urea in 
mg % 
43 
(28 to 
80) 
42 
(24 to 
80) 
41 
(30-
108) 
28 30 32 92 63 
Serum 
creatinine in 
mg % 
1.5 
(0.8 
to 
3.8) 
1.6 
(1.0 to 
3.8) 
2.4 
(1.1 to 
3.8) 
0.8 1.0 1.0 3.8 2.0 
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Table VII 
AETIOLOGICAL DIAGNOSIS AND HISTOPATHOLOGICAL 
FEATURES 
 
Pathological diagnosis No. of cases Percentage 
Membranous Lesion 11 44 % 
Membrano Proliferative 4 16 % 
Mesangio proliferative 4 16 % 
Focal segmental glomerulo Sclerosis 1 4 % 
Chronic glomerulonephritis 1 4 % 
Acute interstitial nephritis  
(native drug intake) 1 4 % 
Multiple myeloma 1 4 % 
Amyloidosis 2 8 % 
  
Majority of the lesions belonged to membranous glomerulopathy 
(44%). History of native drug ingestion in one case, probably the reason for 
renal involvement in the form nephrotic syndrome, was noted. 2 cases of 
amyloidosis secondary to tuberculosis was noted. One case of multiple 
myeloma producing nephrotic syndrome was also noted. 
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HISTOPATHOLOGICAL FEATURES
44%
16%
16%
4%
4%
4%
4% 8%
Membranous Membrano proliferative
Mesangio proliferative Focal segmental glomerulo sclerosis
Chronic glomerulo nephritis Acute Interstitial nephritis
Multiple myeloma Amyloidosis
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DISCUSSION 
Nephrotic syndrome may occur due to a number of cases.  In this 
study, out of 25 cases, 20 cases (80%) were due to primary glomerular 
disorders. One case (4%) of chronic glomerulonephritis, one case (4%) of 
multiple myeloma, 2 cases (8%) of amyloidosis secondary to tuberculosis 
and one case (4%) following the ingestion of negative drug presented as 
nephrotic syndrome were also noted in this study.   In this study, among the 
primary glomerular diseases, membranous lesion was in 44% of cases, 
membranoproliferative lesion in 16% of cases, mesangioproliferative in 16% 
of cases, focal segmental glomerulosclerosis in 4% of cases. 
Age Incidence: 
 Membranous glomerulopathy is unusual in children and adolescents, 
although it may occur at any age, It has a peek incidence between the ages of 
30 to50 years. Membrano profilerative lesion occurs commonly in young 
adults below the age of 30 years. In mesangioproliferative lesion, any age 
can be affected but patients are usually older children and young adults. 
Focal segmental glomerulosclerosis more commonly occurs in younger age 
groups but has been reported to be present in 7% of renal biopsy of elderly 
patients with nephrotic syndrome. In case of multiple myeloma the average 
age group affected is 55yrs (31-77yrs). 
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 In this study, major incidence was noted in 50-55 years of age (52%) 
and minimum incidence was noted in 71-75 years of age group  (4%).  The 
study of average age incidence in various type of glomerulonephritis 
revealed that membranous nephropathy in 59 years, membranoproliferative 
54 years, masangioprolifertive 58 years, focal segmental glomerulosclerosis 
55 years, chronic glomerulonephritis 54 years, acute interstitial nephritis    
55 years, amyloidosis 68 years, multiple myeloma 55 years. 
Sex incidence: 
 Males outnumbered females in this study.  The male : female ratio is 
7:3.  Various authors like Sharma et al and Hanashetty et al also showed 
male preponderance.  Mukherjee 50 reported a female incidence of 31% 
whereas Shanbag 49 reported 26.6%.  In membranous glomerulopathy, males 
are affected twice as frequently as females.  In membrano proliferative 
lesion the sex ratio is equal.   Minimal change disease in children commonly 
affects males but in adults the male to female ratio is equal.  Mesangio 
proliferative lesion also shows male preponderence.In case of multiple 
myeloma, females are affected more than males (male:female ratio is 1:4)  In 
this study, male female ratio for membranous nephropathy, membrano 
proliferative is 2:1 and 3:1 respectively.  In case of amyloidosis male: female 
ratio is equal in this study. In other types of lesion, males are predominantly 
affected. 
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MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (PAS STAIN) 
 
 
 
 
 
 
 
 
 
 
 
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS – METHANAMINE 
SILVER STAIN 
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IMMUNOFLUORESCENCE OF MEMBRANOPROLIFERATIVE 
GLOMERULONEPHRITIS – TYPE I. 
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FOCAL SEGMENTAL GLOMERULOSCLEROSIS – TYPICAL LESION. 
 
 
 
 
 
 
 
 
 
 
 
 
 
FOCAL SEGMENTAL GLOMERULOSCLEROSIS –METHANAMINE SILVER 
STAIN. 
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MEMBRANOUS GLOMERULONEPHRITIS – PAS STAIN. 
 
 
 
 
 
 
 
 
 
 
 
 
IMMUNOFLUORESCENCE OF GLOMERULUS IN MEMBRANOUS 
GLOMERULONEPHRITIS. 
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RENAL AMYLOIDOSIS 
 
 
 
 
 
 
 
 
 
 
 
 
RENAL AMYLOIDOSIS - METHANAMINE SILVER STAIN 
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RENAL AMYLOIDOSIS – CONGO RED POSITIVE AMYLOID DEPOSITS 
 
 
 
 
 
 
 
 
 
 
 
RENAL AMYLOIDOSIS – APPLE GREEN BIREFRINGENCE OF CONGO RED 
POSITIVE AMYLOID MATERIAL IN A GLOMERULUS UNDER POLARISED 
LIGHT. 
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MYELOMA CAST NEPHROPATHY. 
 
 
 
 
 
 
 
 
 
 
 
DRUG INDUCED ACUTE INTERSTITIAL NEPHRITIS. 
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Clinical features: 
 Kark et al says that in the nephrotic syndrome almost all patients will 
present with anasarca, the onset being gradual.  In this study, it was observed 
that anasarca occurred in 100% of cases, ascites in 32% of cases, 
hypertension in 32% of cases, and oliguria in 56% of cases.  Since we found 
significant hypoproteinemia in all the cases, we attributed the massive 
edema secondary to proteinuria, though other factors also played a part in its 
production.  In Shanbag’s series, all of them had massive edema. 49 Sharma 
et al also reported massive edema in the majority of the cases.  Mukherjee 
reported 18% of his patients had ascites in his series. 50 
 Hypertension is seen in about a third of the patients. Cameron et al 
described hypertension as a frequent finding.  West found that patients often 
had hypertension when they first presented, then it would subside and 
reappear years later when they develop chronic renal failure.  In addition, in 
elderly we cannot be certain about the renal cause of hypertension in a 
particular case because the hypertension may be due to superimposed 
essential hypertension as stated by Cameron. 
 Though the blood volume and plasma volume are usually within 
normal limits, de wardener noted that the blood volume markedly changes 
when the patient assumes an upright position after lying in supine position 
for sometime and hence the patient may suffer from orthostatic hypotension.  
This study did not reveal any postural hypotension. 
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Proteinuria: 
 The various reports by different authors suggest that the amount of 
proteinuria has no role in identifying particular type of lesion since any 
amount of protein may be lost in any lesion.  Hardwicke and Squire 
developed the concept of selectivity of proteinuria from the observation that 
proteins of different molecular weight are excreted in the urine in differing 
quantities in various histological forms of nephrotic syndrome.  Selectivity 
index is the ratio of the clearance of individual proteins to the clearance of a 
reference protein such as albumin or transferrin.  If the value is less than 0.1 
it is highly selective, moderately selective if it is between 0.11 to 0.20 and 
poorly selective if its is > 0.20. 
 
 This study shows that proteinuria in cases of membranous 
nephropathy, membranoproliferative and mesangioproliferative lesions as 
3.31 to 4.66 gm, 3.20 to 5.59 gm, 3.80 to 4.25 gm of protein excretion in 
24hours respectively.  In case of chronic glomenulonephritis 4.2 gm, acute 
interstitial nephritis 6.73 gm, multiple myeloma 6.8 gm, amyloidosis 3.78gm 
and in focal segmental glomonulosclerosis as 3.86 gm per 24 hours. 
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 Proteinuria by various authors in various types of lesion is reported as 
follows.  5.98 per 24 hrs (Shanbag) 4.5 gm/24 hrs (Mukherjee) in minimal 
lesion, 7.1 gm/24 hrs (Mukherjee) 6.6 gm/24 hrs ( Shanbag) in membranous 
lesion, 6.4 gm/24 hrs (Mukherjee) 5.5 gm / 24 hrs (Shanbag) in membrano 
proliferative lesion, 5.9 gm/24 hrs (Shanbag) 5.7 gm/24 hrs (Mukherjee) in 
mesangio proliferative lesion.  Shanbag reported 6.2 gm/24 hrs in sclerosing 
lesion.  Thus the various report suggest that the amount of proteinuria has no 
role in identifying particular type of lesion, since any amount of protein may 
be lost in any lesion. 
Haematuria: 
 The precise origin of red blood cells in the urine in glomerular disease 
is not well known.  They gain access to Bowman’s space by passing through 
the occasional rents or tears in the glomerular capillary wall.  Red cells may 
also enter the urine via extra vasation from the peritubular capillaries.  When 
red cells are present in the tubular lumen proximal to the site of Tamm-
Horsfall secretion, they may be incorporated into a matrix composed of 
Tamm-Horsfall protein to produce red cell casts.  Heyman showed that red 
cells in the urine of nephrotics are usually intact in contrast to many lysed 
cells found in the smoky brown urine of patients with acute nephritis.  In this 
study, microscopic hematuria is found in 36% of cases, most of the 
membranous nephropathy type and also in membranoproliferative and 
chronic glomenulonephritis. 
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Serum protein: 
 Serum protein levels are depressed below normal in most of the 
patients with massive proteinuria.  There is an approximate correlation 
between the degree of proteinuria and the extent of hypoproteinemia.  
Mallick et al, Heyman W et al, Newmark S.R. et al, Kahnna UB et al and 
Katiyar et al found a negative correlation between serum protein and 
cholesterol.  In this series all patients were having a low serum protein and a 
high cholesterol value.  Hypoproteinemia may be due to urinary loss, 
increased protein catabolism and decreased protein synthesis.  Existence of 
an intestinal loss of proteins and poor protein intake were also explained. 
Serum cholesterol: 
 Hyperlipidemia forms an important component of nephrotic 
syndrome.  The reduced plasma oncotic pressure from hypoproteinemia 
results in enhanced hepatic production and interferes with their peripheral 
utilization and catabolism.  Khanna UB et al showed that there was a 
positive correlation between the degree of proteinuria and hyperlipidemia 
and a negative correlation between hypoproteinemia and hyperlipidemia.  
Mallick et al and new Mark SR et al also observed the same finding.  In this 
study, all patients are having hypercholesterolemia. 
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 However the western studies differ from this series in an important 
aspect.  The average values in this study were lower than those observed by 
the western authors.  This difference in the lipid pattern could be due to 
different dietetic pattern of our people as regards to the carbohydrate and fat 
content of the diet. 
Histopathological correlation: 
Membranous lesion: 
 44% of patients of this study belonged to this histopathological group.  
Other reported it to be 44% (Moorthy and Zimmerman, 1980),                 
37% (Ishimuto et al, 1981) 69% (Lustig et al, 1982) 52% (Zech et al, 1982), 
50% (Kingwood et al, 1984), 33% (Murphy et al, 1987) 50% (Sato et al, 
1987), 66% (Johnston et al, 1992) 65% (Ozono et al, 1994), 48% (Shin et al, 
2001), 38% (Brown). 21,30-39 Membranous glomerulopathy was found to be 
the commonest histopathological lesion in elderly nephrotics.  Membranous 
nephropathy in this study accounted for 11 out of 25 cases.  In this study, the 
disease was insidious in onset and all the patients presented with anasarca.  
50% of patients with membranous nephropathy presented with scanty 
mictuirition.  4 patients (40%) had ascites and 3  patients (30%) had 
hypertension.  Microscopic haematuria was found in 54% of patients with 
this histological type. 
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Membranoproliferative lesion: 
 4 out of 25 cases in this study (16%) showed evidence of 
membranoproliferative glomerulonephritis.  The other reports are             
11% (Fawcett et al, 1971) 50% (Huriet et al, 1975), 6% (Moorthy and 
Zimmerman, 1980) 12% (Ishimuto et al, 1981), 8% (Lustig et al, 1982),     
6% (Zech et al, 1982) 9% (Kingswood et al, 1984) 33% (Murphy et al, 
1987), 12% (Sato et al 1987), 20% (Ozono et al, 1992), 14% (Shin et al, 
2001), 7% (Brown). 21,28-38 Huriet et al showed this type was the commonest 
lesion in his study.  This lesion is gaining importance in a transplanted 
kidney and associated with low C3 complement and also called as 
Hypocomplementemic nephritis (or) Type II membranoproliferative 
glomerulonephritis.  All the patients presented with anasarca and 75% of 
them had ascites, 50% of the patients presented with scanty mictuirition. 
One out of 4 patients had hypertension.  2 patients had microscopic 
hematuria.  Brunner stated that 25-30% of patients presented with acute 
nephritic syndrome.  This study showed 25% of patients with this 
histological type were having azotemia. 
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Mesangioproliferative lesion: 
 16% of patients of this study belonged to this group.  The other 
reports are 20% (Moorthy and Zimmerman 1980), 3% (Zech et al, 1982), 
34% (Kingwood et al, 1984), 21% (Sato et al 1987), 10% (Johnston et al, 
1992). 30,33,34,36,37 In this study, the disease was insidious in onset and all the 
patients presented with anasarca and 75% of the patients presented with 
scanty mictuirition and ascites was present in 1 patient (25%).  All patients 
had hypertenion.  Asymptomatic haematuria with or without proteinuria is a 
common clinical feature of this lesion but this study showed no haematuria.  
Azotemia was present in 1 patient (25%). Johny KV stated that acute anuria 
at the onset and its persistence for over 3 weeks often indicates 
extracapillary form of glomerulonephritis and poor prognosis.  On clinical 
grounds alone, it is difficult to separate this goup of patients from those with 
minimal change disease. 
Focal segmental glomerulosclerosis: 
 One patient in this study showed evidence of focal segmental 
glomerulo sclerosis (4%).  In other studies  it was 44% (Fawcett et al, 1971), 
3% (Moorthy and Zimmerman, 1980), 50% (Ishimuto et al 1981),              
3% (Johnston et al 1992).  28,30,31,37 Fawcett et al and Ishimutto et al showed 
that it was the commonest lesion in their study.  This patient presented with 
anasarca, proteinuria, hypoalbuminemia, hypercholesterolemia, but not with 
hypertension, azotemia or haematuria. 
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Chronic glomerulanephritis: 
 One case in this study (4%) belonged to chronic glomerulonephritis.  
Fawcett et al 28 in his study of 36 cases of elderly nephrotic syndrome 
reported 5 cases (13%).  Zech et al 33 reported as 5%, and Shin et al 39 
reported chronic glomerulonephritis as a cause of elderly nephrotic 
syndrome in 0.5% of cases in his study.  This patient presented with 
insidious onset of anasarca, scanty mictuirition and microscopic haematuria 
but normotensive and was not having azotemia. 
Acute interstitial nephritis: 
 One patient of this study 4% showed evidence of acute interstitial 
nephritis and one case of membrano prolifertive nephritis also showed 
superimposed interstitial nephritis (Case no. 24).  In this study, this patient 
presented with anasarca and scanty mictuiration without haematuria or 
azotemia. 
Native drug: 
 A single case of nephrotic syndrome following native drug ingestion 
was noted in this study.  Native drugs usually contain heavy metals like 
mercury, lead, arsenic etc.  in powder form.  It is a well known fact that 
these drugs can cause nephrotic syndrome by its nephrotoxicity.  Our case 
presented after a week of ingestion of the drug.   
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Though there is a possibility of independent primary glomerular 
disease causing nephrotic syndrome in this patient, because of ingesion of 
native drug we attributed the cause of nephrotic syndrome to the native drug, 
which must have had the heavy metal.  There are some case reports in the 
literature by various authors (Brown, Munch and Nissen, Preedy and 
Ruissel, Riddle, Heptinstall).  The case report of Samitz et al is interesting 
because he was the first person who explained that the nephrotic syndrome 
can occur due to a definite allergy to the heavy metal affecting glomeruli 
rather than due to its toxic effect on proximal convoluted tubule.  Beckar et 
al reported 6 cases of this type and came to the conclusion that the onset of 
membranous glomeralonephritis frequently followed an immunologic event.  
Barr et al reported minimal lesions on light microscopy.  Our case showed 
acute interstitial nephritis type lesion on light microscopy. 
Multiple myeloma: 
 One case of this study (4%) belonged to this group.  In this study, this 
patient presented with anasarca, hypercholesterolemia and azotemia but was 
not hypertensive and showed no haematuria.  In various studies done by 
Confalonieri R. et al 41 (1988), Ganeval D. et al 43 (1984), Buxbaum J.N. et 
al 42 (1990), Heilman R.L. et al 44 (1992) and Lin et al 45 (2001), multiple 
myeloma presented with haematuria in 45% of cases, azotemia in 90% of 
cases.   
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58% of patients were hypertensive and 23-67% of multiple myeloma 
patients had nephrotic range of proteinuria.  High prevalence, early 
appearance and severe renal failure are other salient features of Monoclonal 
immunoglobulin deposition disease. (Randal et al 1976, Tubbs et al 1981, 
Lin et al 2001 and Ronco et al 2001) 45-48 
Amyloidosis: 
 Two cases of amyloidosis (81%) secondary to tuberculosis is noted in 
this study.  In thirty percent of elderly patient in medical Research Council 
Glomerulo nephritis Registry from 1978 to 1990, biopsied for nephrotic 
syndrome that showed renal amyloidosis in 10.7% of cases.  Other reports 
are S. Prakash (22.8%), Dixon (14%), Shanbag (10.4%), Brown 21 (15%) 
and Johny (2.1%) Mittel et al studied 29 cases of renal amyloidosis, out of 
which 20 cases were due to tuberculosis.  Lampa S et al reported 3 cases out 
of     12 cases of nephrotic syndrome. 
There are so many single case reports from various parts of our 
country.  Sarin has brought to light that amyloidosis is not a rare disease in 
our country and this has been more recently supported because of the 
availability of sophisticated techniques by other workers like Chugh et al, 
Mathur and Srinivasan, Tyagi and Wagi.  They put the incidence at nearly 
27% in all renal biopsy specimens.   
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The frequency of amyloidosis at large or even in all populations with 
a high risk is not known.  Most of the available information has been on the 
antemortum or postmortum prevalence study of few of the selected 
population.  (Patients known to have leprosy, TB so forth) In western 
literature, there is a general agreement that the apparent incidence of 
secondary amyloidosis is decreasing, while there is an increase in primary 
amyloidosis.  The increase in incidence of primary amyloidosis reflects an 
increased awareness and better diagnostic tools, whereas the decrease in 
secondary amyloidosis may be due to earlier detection of cases and 
immediate treatment of causes.  This can be easily evident from the reports 
of Kayle and Bayrd in 1975 who reported absence of secondary amyloidosis 
due to tuberculosis, whereas Dixon in 1968 has reported the incidence of 
14% due to tuberculosis. 
 The interesting controversial phenomenon centering on amyloidosis is 
the correlation between it and blood pressure.  Hypertension was noted to be 
frequent in the 42 patients described by Brandt, Catchcart and Cohen but, in 
contrast to this, Heptinstall and Joekas found normal pressure in their cases, 
as noted in this study.  Bentwich, Roseman, and Eliakins (1971) in a special 
investigation into the prevalence of hypertension in renal amyloidosis, found 
it to be present in 20% of a series of 50 patients.   
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They came to a conclusion after careful studies of cases of 
amyloidosis that hypertension results with very extensive renal involvement 
and with vessel wall deposits producing intimal fibrosis and cystic medial 
hypertrophy. 
 Analysis of the patients with various histological appearance will 
reveal the fact that unlike clinical syndromes which have a quite variable 
prognosis, the histological data provide on excellent guide to the outcome of 
the patient.  Three major histological patterns were observed by Cameron 
and Chugh et al. 
1. In patients with normal or nearly normal looking glomeruli acute 
exudative lesions, proliferation confined to the mesangium and focal 
proliferative disorders without systemic vasculitis, death from renal 
failure was unusual. 
2. When there is obvious structural damage with scarring such as 
membranous nephropathy, focal segemental sclerosis, proliferative 
glomerulonephritis and membranoproliferative glomerulonephritis, 
there is a steady progressive mortality. 
3. Patients with extensive crescent formation as well as glomerular 
proliferation do very badly with a fulminant course. 
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Comparison of histopathological lesions with various 
studies 
 
 
Histopathological 
lesion 
Fa
w
ce
tt
 
et
 
a
l (
19
71
) 
M
o
o
rt
hy
 
a
n
d 
Zi
m
m
er
m
a
n
 
(19
80
) 
Is
hi
m
u
to
 
et
 
a
l (
19
81
) 
Ze
ch
 
et
 
a
l (
19
82
) 
Jo
hn
st
o
n
 
et
 
a
l (
19
82
) 
K
in
gs
w
o
o
d 
et
 
a
l 
(19
84
) 
Br
o
w
n
 
(19
86
) 
Sa
to
 
et
 
a
l (
19
87
) 
Sh
in
 
et
 
a
l (
20
01
) 
Th
is 
st
u
dy
 
Minimal change 17 27 7 33 21 7 18 13 26 - 
Membranous 14 44 37 52 66 50 38 50 48 44 
Membrano 
proliferative 11 6 12 7 - 9 7 14 14 16 
Mesangio 
proliferative - 20 - 3 10 34 6 21 - 16 
Glomerulo 
sclerosis 44 3 44 - 3 - - 2 11.5 4 
Chronic 
glomerulo 
nephritis 
14 - - 5 - - - - 0.5 4 
Amyloidosis - - - - - - 15 - - 8 
Multiple 
myeloma - - - - - - - - - 4 
Other - - - - - - 17 - - 4 
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CONCLUSION 
 A study of clinical features, biochemical changes and 
histopathological examination of renal biopsy specimens was done in          
25 patients with nephrotic syndrome admitted in Thanjavur Medical College 
Hospital between December 2003 to July 2005. 
1. The maximum incidence occurred in the sixth decade of life. 
2. The male to female ratio is 7:3. 
3. The most common cause of nephrotic syndrome was found to be 
primary glomerular disease (80%).  Membranous glomerulopathy 
was the commonest histopathological lesion.  
4. Some rare cases of nephrotic syndrome due to amyloidosis, multiple 
myeloma, drug toxicity were also noted. 
5. Presence of hypertension, hematuria, azotaemia correlated with 
membranous gromerulopathy, membranoproliferative and 
mesangioproliferative, multiple myeloma and amyloidosis. 
6. Hypertension, azotemia and hypercholesterolemia were observed in 
32%, 32% and 100% respectively.  This suggests that hypertension 
and azotemia are not uncommon in nephrotic syndrome. 
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CLINICOPATHOLOGICAL CORRELATION OF 
NEPHROTIC SYNDROME IN ELDERLY PATIENTS 
 
PROFORMA 
 
Name:    Age:    Sex: 
 
Address:    DOA:    DOD: 
 
I.P. No.: 
 
Presenting Symptoms: 
 
Puffiness of face    Abdominal distention 
Swelling of legs    Bone pain 
 
Oliguria     Headache 
 
Haematuria     Others 
 
Previous Illness 
 
Hypertension    Diabetes mellitus 
Drug intake     Native medicine intake 
 
Previous renal disease 
 
Personal History 
 
Smoking     Alcohol intake 
 
General Examination 
 
Height    Weight   Pulse 
Anemia    Skin lesion   BP 
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Facial puffiness     JVP 
Pedal Odema 
CVS :      Abd  : 
RS :      CNS  : 
       Fundus : 
Investigations 
Urine  Albumin 
 
  Sugar 
   
  Deposit 
 
  24hrs urine protein 
  
  Culture and sensitivity 
 
  Bence Jones protein 
 
Blood: Hb   Sugar   St. protein 
 
  TC   Urea   Albumin 
   
  DC   Creatinine  Globulin 
 
  CT 
 
  RBC   St. Cholesterol 
 
  ESR 
 
- USG Abdomen   X-ray – KUB 
 
- Renal Biopsy: Date : 
   No. : 
        HPE Report : 
Remarks: 
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